Corona patients were treated and released healthy


Knitted News30.09.20 21:36 Twelfth of Tishrei Tishpa

(Photo: Yossi Aloni / Flash 90)

Good news: Today (Wednesday) the fifth of the five most difficult and critical patients suffering from the corona virus was released to his home, from those who received innovative treatment in the world’s first clinical trial, in the treatment of human cells taken from a healthy donor.

The five corona patients, 3 of them in critical condition and 2 in critical condition, were treated at Hadassah Ein Kerem Hospital under a clinical trial with an innovative drug, Alostra, developed at Hadassah in collaboration with the biotechnology company Analybax Therapeutics.

More on the same topic

Data revealed: Percentage of positive tests in each sector


All five patients were discharged healthy from the hospital after treatment on average five to six days after receiving the drug, and all were negative for the corona virus on the day of discharge.

“Alostra” was developed on the basis of research by Prof. Dror Mevorach – Head of the Internal Medicine and Corona Department at Hadassah, and has already been successfully tried in the past in ten patients with sepsis (sepsis), which is considered a serious disease that currently has no cure.

“Alostra is intended for the treatment of a wide range of cases in which there is an overactivity of the immune system, which leads to an increase in the secretion of proteins by cells of the immune system – called cytokines and causing a cytokine storm,” explains Prof. Mevorach.

Prof. Dror Mevorach (Courtesy: Hadassah Spokeswoman)

“Its activity is carried out by treating cells taken from a healthy donor and Hindus in the laboratory in such a way that they, when injected into the patient’s body, curb the inflammation or cytokine storm that is very harmful to patients.”

The trial of Corona patients was conducted under the approval of the Helsinki Committee of the Ministry of Health, and the lead researcher in the trial was Prof. Van Jordan, director of the intensive care unit at Hadassah Ein Kerem Hospital.

Hadassah CEO Prof. Zeev Rothstein: “Despite the war around and alongside intensive preparations to absorb the growing numbers of critically ill patients, Hadassah continues to innovate and lead the breakthroughs in the treatment of these corona patients and are happy that a drug developed within our hospital walls does show therapeutic potential in these patients . I hope that even those who must do their part in the budget and cash flow of the hospital system in the country, will finally wake up and help us help the public at this time. “

Did you find a mistake in the article? Does the content in the article infringe your copyright? Encountered an inappropriate advertisement? Report to us

Source link by

*The article has been translated based on the content of Source link by
. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!


Please enter your comment!
Please enter your name here